CENPN and nasopharyngeal carcinoma: Thus, we confirmed that CENPN inhibits p-CREB entry into the nucleus by direct protein‒protein binding, thereby reducing the transcriptional activity of VAMP8, leading to PTX resistance and a poor prognosis in NPC patients (Figure 10F).